|Podcasts|November 11, 2021
Episode 95: CEOs Share Their Industry Outlook
Author(s)Elaine Quilici, Miranda Schmalfuhs
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
Advertisement
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
2
From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI
3
EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%
4
Augmentin XR Becomes First Approval Under Commissioner’s National Priority Voucher Pilot Program
5
